These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9726699

  • 21. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
    Kaukonen KM, Olkkola KT, Neuvonen PJ.
    Eur J Clin Pharmacol; 1998 Feb; 53(6):445-9. PubMed ID: 9551703
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T, Kivistö KT, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole.
    Raaska K, Niemi M, Neuvonen M, Neuvonen PJ, Kivistö KT.
    Clin Pharmacol Ther; 2002 Oct; 72(4):362-9. PubMed ID: 12386638
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Levosimendan: implications for clinicians.
    McBride BF, White CM.
    J Clin Pharmacol; 2003 Oct; 43(10):1071-81. PubMed ID: 14517189
    [Abstract] [Full Text] [Related]

  • 28. Population pharmacokinetics of levosimendan in patients with congestive heart failure.
    Jonsson EN, Antila S, McFadyen L, Lehtonen L, Karlsson MO.
    Br J Clin Pharmacol; 2003 Jun; 55(6):544-51. PubMed ID: 12814448
    [Abstract] [Full Text] [Related]

  • 29. Effect of itraconazole on the pharmacokinetics of inhaled lidocaine.
    Isohanni MH, Neuvonen PJ, Olkkola KT.
    Basic Clin Pharmacol Toxicol; 2004 Sep; 95(3):120-3. PubMed ID: 15447735
    [Abstract] [Full Text] [Related]

  • 30. Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine.
    Isohanni MH, Neuvonen PJ, Olkkola KT.
    Pharmacol Toxicol; 1999 Mar; 84(3):143-6. PubMed ID: 10193676
    [Abstract] [Full Text] [Related]

  • 31. Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole.
    Raaska K, Neuvonen PJ.
    Eur J Clin Pharmacol; 1998 Apr; 54(2):167-70. PubMed ID: 9626923
    [Abstract] [Full Text] [Related]

  • 32. Levosimendan, a new calcium-sensitizing inotrope for heart failure.
    Ng TM.
    Pharmacotherapy; 2004 Oct; 24(10):1366-84. PubMed ID: 15628834
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure.
    Sandell EP, Hayha M, Antila S, Heikkinen P, Ottoila P, Lehtonen LA, Pentikainen PJ.
    J Cardiovasc Pharmacol; 1995 Oct; 26 Suppl 1():S57-62. PubMed ID: 8907132
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Levosimendan: a new option in acute cardiac failure.
    Holley AD, Ziegenfuss M.
    Emerg Med Australas; 2006 Oct; 18(5-6):505-9. PubMed ID: 17083641
    [No Abstract] [Full Text] [Related]

  • 36. Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism.
    Araki K, Yasui-Furukori N, Fukasawa T, Aoshima T, Suzuki A, Inoue Y, Tateishi T, Otani K.
    Eur J Clin Pharmacol; 2004 Aug; 60(6):427-30. PubMed ID: 15232663
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The contractility enhancing effect of the calcium sensitiser levosimendan is not attenuated by carvedilol in healthy subjects.
    Lehtonen L, Sundberg S.
    Eur J Clin Pharmacol; 2002 Oct; 58(7):449-52. PubMed ID: 12389066
    [Abstract] [Full Text] [Related]

  • 39. Itraconazole increases serum digoxin concentration.
    Partanen J, Jalava KM, Neuvonen PJ.
    Pharmacol Toxicol; 1996 Nov; 79(5):274-6. PubMed ID: 8936563
    [Abstract] [Full Text] [Related]

  • 40. Safety of levosimendan and other calcium sensitizers.
    Lehtonen L, Mills-Owens P, Akkila J.
    J Cardiovasc Pharmacol; 1995 Nov; 26 Suppl 1():S70-6. PubMed ID: 8907134
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.